Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on May 1, 2026

May 1, 2026

Future Mineral Announces Management and Board Changes; Engages Native Ads for Investor Relations

Indeterminate GlobeNewswire

May 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

Carbonara Announces Run for U.S. Congress in Florida's Redrawn 22nd District

Indeterminate GlobeNewswire

May 1, 2026

Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

Indeterminate GlobeNewswire

May 1, 2026

Fort Lauderdale Commissioner John Herbst Endorses Michael Carbonara for Congress in FL-22

Indeterminate GlobeNewswire

May 1, 2026

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Indeterminate GlobeNewswire

May 1, 2026

Albany State University Showcases Student Innovation at 14th Annual Undergraduate Research Symposium

Indeterminate EIN Presswire

May 1, 2026

Trident Announces Receipt of Nasdaq Determination Letter and Intent to Request Hearing

Indeterminate GlobeNewswire

May 1, 2026

HII’s Ingalls Shipbuilding Hosts “Signing Day” Celebrating Shipbuilder Academy Graduates

Indeterminate GlobeNewswire

May 1, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

Northrop Grumman Honors Top Suppliers Driving Industrial Innovation

Indeterminate GlobeNewswire

May 1, 2026

NOVAGOLD Announces Date of Its 2026 Virtual Annual General Meeting of Shareholders

Indeterminate GlobeNewswire

May 1, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation

Indeterminate GlobeNewswire

May 1, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

May 1, 2026

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

Indeterminate GlobeNewswire

May 1, 2026

InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

Indeterminate GlobeNewswire

May 1, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire